Sterility Testing — Compendial Limits & Aseptic Technique

A sterility test examines samples from a sterilized batch for viable contamination. Because the test samples a small fraction of the batch under aseptic conditions, it supports — but cannot by itself demonstrate — the sterility assurance delivered by a validated process.

Understand the statistical limitation

Compendial sterility tests examine a defined number of units; a passing result does not prove every unit is sterile, and a contaminated test environment can produce a false failure. Treat the test as one element of batch release alongside the validated sterilization cycle and process controls, and ask the laboratory how its aseptic handling and environmental monitoring are documented.

Establish method suitability per product

Products with antimicrobial activity can mask contamination. Suitability (bacteriostasis/fungistasis) testing demonstrates that the method can recover low levels of organisms in the presence of the product. Agree the neutralization or membrane-filtration approach before routine testing begins, and re-examine suitability when formulations or materials change.

Define what happens on a failure

A sterility failure triggers a defined investigation: test invalidity versus genuine contamination has regulatory and supply consequences. Ask how the laboratory documents its own controls, whether a repeat test is scientifically justified, and how records support the manufacturer's batch decision. The laboratory reports evidence; disposition remains the manufacturer's responsibility.

Validation and microbiological testing are different evidence

Sterilization validation establishes a defined process for the actual device and load. Sterility, bioburden and endotoxin tests answer different questions; a negative sterility result does not prove every unit sterile. Agree method suitability, recovery, product inhibition, sampling and sterilizer/laboratory responsibilities before work begins.

What to include in your buyer brief

Start with the decision the work must support. Unknown details can be clarified after the initial inquiry.

Product, materials/formulation, patient or drug contact, contact duration, intended use and target market; identify changed materials, suppliers or processes.
Finished configuration, sample count and lots, sterilization modality/cycles, aging and storage history; justify worst-case variants and destructive allocations.
Existing evaluation plan, drawings, specifications, methods/editions, previous reports and acceptance criteria; send confidential files only through the private intake.
Required report, quality/accreditation scope, budget range, location, shipping constraints and decision deadline; ask the provider to explain exclusions and subcontracted work.

Sample considerations

Provide product, packaging, fill or device configuration and the sterilization history of the batch.
Identify any antimicrobial properties and the required pharmacopoeia and sample quantity.
Agree shipping conditions, test article selection and retained samples for investigation.

Questions to ask a laboratory

How is method suitability demonstrated and kept current for this product?
What environmental and negative controls accompany each test?
How is a positive result investigated and documented before reporting?

Laboratories with relevant capabilities

Pace Analytical Life Sciences (Oakdale, MN) — Microbiology
Canyon Labs (Bluffdale, UT) — Microbiology Testing
Micro-Serve Laboratorium (Veenendaal, Utrecht) — Microbiology Testing
Nelson Laboratories (Salt Lake City, UT) — Microbiology
BA Sciences (Salem, NH) — Microbiology
Medistri (Domdidier, Fribourg) — Sterility Testing

Frequently asked questions

Is a passing sterility test proof a batch is sterile?: No. It is one element of sterility assurance; the sterilisation process validation and controls carry most of the weight.